alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 15,351–15,375 of 27,380 studies, newest first · page 615 of 1096.

February 2017 25

  1. 2017-02-05

    Survival after dementia diagnosis in five racial/ethnic groups

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Survival after dementia diagnosis differs by race/ethnicity, with shortest survival among whites and longest among Asian Americans. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2017-02-05

    Factors associated with the quality of life of family carers of people with dementia: A systematic review

    ✓ Peer-reviewed Caregiving Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The quality and level of evidence supporting each theme varied. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2017-02-04

    Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease

    ✓ Peer-reviewed Risk factors Progress in molecular biology and translational science

    Key finding: Among them, SIRT3 is exclusively present in mitochondria, playing a significant role in metabolic adaptation.

    Full summary, score breakdown and related studies → Original source

  4. 2017-02-04

    Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology

    ✓ Peer-reviewed Tau biomarkers Journal of psychiatric research

    Key finding: Evaluating the subject's personality changes may add significant clinical information, as well as help to better understand the interaction between personality change, cognitive decline, and cerebral pathology. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2017-02-03

    Alzheimer disease: CSF biomarkers for Alzheimer disease - approaching consensus

    ✓ Peer-reviewed Tau biomarkers Nature reviews. Neurology

    Key finding: A European working group has provided a new set of recommendations for the use of cerebrospinal fluid (CSF) biomarkers in the diagnostic evaluation of Alzheimer disease and mild cognitive impairment. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2017-02-03

    Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis

    ✓ Peer-reviewed Getting a diagnosis BMJ open

    Key finding: The pooled rate of undetected dementia was 61.7% (95% CI 55.0% to 68.0%).

    Full summary, score breakdown and related studies → Original source

  7. 2017-02-02

    CJD mimics and chameleons

    ✓ Peer-reviewed End-of-life care Practical neurology

    Key finding: We have based this pragmatic review on the experiences of a specialist prion referral centre in the UK, which, unsurprisingly, is strongly biased towards seeing patients with CJD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2017-02-02

    MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression

    ✓ Peer-reviewed Long-term cohort studies Frontiers in aging neuroscience

    Key finding: Late-life depression (LLD) is associated with development of different types of dementia. +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2017-02 month only

    Narrative collisions, sociocultural pressures and dementia: the relational basis of personhood reconsidered

    ✓ Peer-reviewed Caregiving Sociology of health & illness

    Key finding: It is concluded that a sociologically-informed perspective can help to reinforce the academic understanding of personhood.

    Full summary, score breakdown and related studies → Original source

  10. 2017-02-01

    Regulation of Cognitive Processing by Hippocampal Cholinergic Tone

    ✓ Peer-reviewed Disease mechanisms Cerebral cortex (New York, N.Y. : 1991)

    Key finding: Cholinergic dysfunction has been associated with cognitive abnormalities in a variety of neurodegenerative and neuropsychiatric diseases. +2 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2017-02 month only

    Association Between Lithium Use and Risk of Alzheimer's Disease

    ✓ Peer-reviewed Drug development The Journal of clinical psychiatry

    Key finding: We identified 63,347 cases with Alzheimer's disease and 126,694 controls. +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2017-02 month only

    [Amyloid positron-emission-tomography with [18 F]-florbetaben in the diagnostic workup of dementia patients]

    ✓ Peer-reviewed Brain scans and imaging Der Nervenarzt

    Key finding: 17 out of 33 patients were scored as FBB-PET positive. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2017-02-01

    Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration

    ✓ Peer-reviewed Inflammation and the immune system Redox biology

    Key finding: To this end, we generated Gpx4BIKO mouse, a mouse model with conditional deletion in forebrain neurons of glutathione peroxidase 4 (Gpx4), a key regulator of ferroptosis, and showed that treatment with tamoxifen led to deletion of Gpx4 primarily in forebrain neurons of adult Gpx4BIKO mice. +4 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2017-02-01

    Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease

    ✓ Peer-reviewed Drug development JAMA neurology

    Key finding: However, several drugs prescribed for other conditions have been associated with reducing its risk. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2017-02-01

    Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)

    ✓ Peer-reviewed Genetics Brain : a journal of neurology

    Key finding: Molecular defects in this gene have been causally associated with Kufor-Rakeb syndrome (#606693), an autosomal recessive form of juvenile-onset parkinsonism, and neuronal ceroid lipofuscinosis (#606693), a neurodegenerative disorder characterized by the intracellular accumulation of autofluorescent lipopigments. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2017-02-01

    Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

    ✓ Peer-reviewed Tau biomarkers JAMA neurology

    Key finding: The findings suggest that detection of αSyn oligomers by αSyn-PMCA in the CSF of patients affected by PD may offer a good opportunity for a sensitive and specific biochemical diagnosis of the disease. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2017-02-01

    Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults

    ✓ Peer-reviewed Biomarkers Brain, behavior, and immunity

    Key finding: Studies on markers of inflammation in subjects with mild cognitive impairment or AD dementia provided inconsistent results. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2017-02-01

    Sex differences in the association between AD biomarkers and cognitive decline

    ✓ Peer-reviewed Hippocampus size on brain scans Brain imaging and behavior

    Key finding: Previous autopsy work has suggested that, in the presence of AD neuropathology, females are more susceptible to the clinical manifestation of AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2017-02-01

    α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

    ✓ Peer-reviewed Inflammation and the immune system Nature medicine

    Key finding: Furthermore, α-synuclein contributes to the fibrilization of amyloid-b and tau, two key proteins in Alzheimer's disease, which suggests a central role for α-synuclein toxicity in neurodegeneration. +3 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2017-02-01

    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants

    ✓ Peer-reviewed Long-term cohort studies European heart journal

    Key finding: Cardiometabolic diseases (hypertension, coronary artery disease [CAD] and diabetes are known to associate with poorer cognitive ability but there are limited data on whether having more than one of these conditions is associated with additive effects. +3 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2017-02-01

    Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Current opinion in lipidology

    Key finding: APOE4 genotype is the strongest genetic risk factor for Alzheimer's disease. +3 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2017-02-01

    Epidemiology of Parkinson's disease

    ✓ Peer-reviewed Lewy body dementia Journal of neural transmission (Vienna, Austria : 1996)

    Key finding: Several environmental factors are associated with increased risk of PD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  23. 2017-02-01

    Vascular Cognitive Impairment

    ✓ Peer-reviewed Brain scans and imaging Circulation research

    Key finding: Vascular cognitive impairment refers to all forms of cognitive disorder associated with cerebrovascular disease, regardless of the specific mechanisms involved. +1 more finding

    Full summary, score breakdown and related studies → Original source

  24. 2017-02-01

    Natural history of pure autonomic failure: A United States prospective cohort

    ✓ Peer-reviewed Getting a diagnosis Annals of neurology

    Key finding: Patients presenting with pure autonomic failure are at high risk of phenoconverting to a manifest CNS synucleinopathy. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2017-02-01

    Validation of olfactory deficit as a biomarker of Alzheimer disease

    ✓ Peer-reviewed Genetics Neurology. Clinical practice

    Key finding: Olfactory identification deficit is a useful screening tool for AD-related amnestic disorder, with sensitivity and specificity comparable to other established biomarkers, with benefits such as ease of administration and low cost.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →